Status:
COMPLETED
The Effect of Ketamine on Sleep Quality in Patients Undergoing Colonoscopy
Lead Sponsor:
Kocaeli City Hospital
Conditions:
Sleep
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Sedation typically begins with 2 mg of midazolam (0.025-0.1 mg/kg), followed by propofol given initially at 0.5-1.0 mg/kg bolus doses, with additional 0.25-0.5 mg/kg boluses as needed every 1-3 minute...
Detailed Description
During colonoscopy procedures, routine procedural sedation and analgesia are typically administered due to expected severe discomfort and pain. Sedation is administered by anesthesiologists using vari...
Eligibility Criteria
Inclusion
- Patients who agree to participate in the study
- Patients undergoing colonoscopy procedures
- Patients classified as ASA 1-2
- Male and female patients aged 18-65 years
Exclusion
- Patients who decline to participate in the study
- Patients allergic to ketamine, propofol, and midazolam
- Patients with acute or chronic pain
- Patients diagnosed with psychiatric disorders
- Patients using antidepressants or sleep medications
- Patients with sleep disorders
- Patients with a history of oncological diseases
- Patients experiencing complications related to colonoscopy procedures
- Patients experiencing complications related to anesthesia administration
- Patients with a body mass index (BMI) \>30 kg/m²
- Patients with cognitive impairment or communication issues
- Pregnant and postpartum patients
- Patients with sleep apnea syndrome
- Patients with uncontrolled hypertension (Blood Pressure \>180/110 mmHg)
Key Trial Info
Start Date :
July 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 6 2024
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT06498869
Start Date
July 30 2024
End Date
October 6 2024
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli City Hospital
Kocaeli, Izmit, Turkey (Türkiye), 41100